Market Research Logo

Global Spinal Cord Stimulation Market Report: 2016 Edition

Global Spinal Cord Stimulation Market Report: 2016 Edition

Chronic pain is an unpleasant sense of discomfort that persists or progresses over a long period of time. A chronic back pain can be treated through spinal cord stimulation (SCS) therapy. It is a process that uses soft thin wires with electrical leads to be placed in the spinal column through needle so as to cure chronic back pain. This process doesn’t eliminate the pain; it just interferes with the signals sent to the brain. The SCS surgery is performed in two stages: trial stimulation and permanent implantation.

Spinal cord stimulation therapy is used to reduce the pain signals that are sent to the brain through spinal cord which in return release pain relief chemicals. For this process, a spinal cord stimulator also known as dorsal column stimulator, is surgically placed under the skin to send a mild electrical current to the spinal cord. The process has its advantages and disadvantages.

The spinal cord stimulation (SCS) market is vast and remains relatively untouched with huge potential to treat widespread chronic back pain. The global SCS market is expected to increase in the coming years. The US has the chronic back pain prevalence with maximum number of addressable population and system implants.

The key factors driving the growth in the SCS market includes increasing adult population in the US, increasing demand for minimally invasive surgeries, innovation of new technologies & therapies, growing cases of obesity, and rise in ageing demographics. However, there are number of factors which are hindering the growth of the SCS market like high cost associated with therapy, tough regulatory approvals, and major reliance on traditional SCS therapy.

The report offers an in-depth analysis of the spinal cord stimulation market segmented into global SCS and regional SCS market, covering the US and outside the US market. Competition in this market is rather concentrated with a few medical device companies dominating the market, through innovation. Medical companies that have been covered in the report include Medtronic Plc., Nevro Corporation, Boston Scientific, and St. Jude Medical."


1. Market Overview
1.1 Introduction
1.2 Electrical Stimulation
1.3 Spinal Cord Stimulator
1.4 Mechanism of SCS
1.5 Treatment by SCS
1.6 Advantages & Disadvantages
1.7 Risks Associated
2. Global Market
2.1 Global SCS Market by Value
Table 1: Global Spinal Cord Stimulation (SCS) Market by Value (2014-2018E)
2.2 Global SCS Market by Region
Table 2: Global Spinal Cord Stimulation (SCS) Market by Region (2016E)
2.3 Global SCS Addressable Population
Table 3: Global SCS Addressable Population (2014-2018E)
2.4 Global SCS System Implants Volume
Table 4: Global SCS System Implants Volume (2014-2018E)
3. Regional Markets
3.1 The US
3.1.1 The US Chronic Back Pain Prevalence
Table 5: The US Chronic Back Pain Prevalence (2014-2018E)
3.1.2 The US Addressable SCS Population
Table 6: The US Addressable SCS Population (2014-2018E)
3.1.3 The US SCS Implant Systems Volume
Table 7: The US SCS Implant Systems Volume (2014-2018E)
3.1.4 The US SCS Treatment by Indication
Table 8: The US SCS Treatment by Indication (2015)
3.1.5 The US SCS Market by Value
Table 9: The US SCS Market by Value (2014-2018E)
3.2 Outside the US
3.2.1 Addressable SCS Population outside the US
Table 10: Addressable SCS Population outside the US (2014-2018E)
3.2.2 SCS Implant Systems Volume outside the US
Table 11: SCS Implant Systems Volume outside the US (2014-2018E)
3.2.3 Rechargeable SCS Market Value outside the US
Table 12: Rechargeable SCS Market outside the US (2015-2020E)
3.2.4 The SCS Market Value outside the US
Table 13: The SCS Market Value outside the US (2014-2018E)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increasing Adult Population in the US
Table 14: Increasing Adult Population in the US (2015-2020E)
4.1.2 Increasing Demand for Minimally Invasive Surgeries
4.1.3 Innovation of New Technologies & Therapies
Table A: New Technologies & Therapies (2015)
4.1.4 Rising Global Healthcare Expenditure
Table 15: Rising Global Health Care Expenditure (2008-2015E)
4.1.5 Growing Cases of Obesity
Table 16: Growing Cases of Obesity (2010-2015E)
4.1.6 Rise in Ageing Demographics
Table 17: Worldwide Ageing Population 60 Years or Older (2000-2030E)
4.2 Trends
4.2.1 Aspects of Choosing SCS Devices in the US
Table 18: Aspects of Choosing SCS Devices (2015)
4.2.2 Increasing Trial Units for SCS Placements in the US
Table 19: Increasing Trial Units in the US (2015-2020E)
4.2.3 Advancements in Spine Therapies
4.2.4 Rising Mergers & Acquisitions in SCS Market
Table B: Major Acquisitions in SCS Market (2015-2016)
4.3 Challenges
4.3.1 Reliance on Traditional SCS Therapy
4.3.2 Tough Regulatory Approvals
4.3.3 High Costs Associated with Therapy
5. Competitive Landscape
5.1 Global SCS Market
5.1.1 Global SCS Market Share
Table 21: Global SCS Comparative Market Share (2015/2018E)
5.1.2 Competition by SCS Technologies
Table C: Competitive SCS Technologies by Companies (2015)
5.2 The US SCS Market Competition
5.2.1 Competition by Market Share
Table 22: The US SCS Market Share by Company (2016E)
5.2.2 Competition by Volume Share
Table 23: The US SCS Volume Share by Company (2016E)
5.3 Competition outside the US
5.3.1 Competition by Market Share
Table 24: The SCS Market Share outside the US by Company (2016E)
5.3.2 Competition by Volume Share
Table 25: The SCS Volume Share outside the US by Company (2016E)
6. Company Profiles
6.1 Nevro Corporation
6.1.1 Business Overview
Table 26: Nevro Corporation Revenue by Region (2015)
6.1.2 Financial Overview
Table 27: Nevro Corporation Revenue and Net Loss (2012-2015)
6.1.3 Business Strategies
6.2 Medtronic Plc.
6.2.1 Business Overview
Table 28: Medtronic Revenue by Business Units (2015*)
6.2.2 Financial Overview
Table 29: Medtronic Revenue and Net Income (2011-2015*)
6.2.3 Business Strategies
6.3 Boston Scientific
6.3.1 Business Overview
Table 30: Boston Scientific Revenue by Business Segments (2015)
Table 31: Boston Scientific Revenue by Region (2015)
6.3.2 Financial Overview
Table 32: Boston Scientific Revenue (2011-2015)
6.3.3 Business Strategies
6.4 St. Jude Medical
6.4.1 Business Overview
Table 33: St. Jude Medical Revenue by Product (2015)
6.4.2 Financial Overview
Table 34: St. Jude Medical Revenue and Net Income (2011-2015)
6.4.3 Business Strategies

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report